IP Library Granted Patent US 11,850,222
Granted Patent B2
US 11,850,222 · App. 17/036,790 · Granted Dec 26, 2023

Sotalol compositions and uses of the same

Inventors: H. Greg Thomas (Carrollton, GA); Jeffrey S. Kiel (Gainesville, GA)
Assignee: ARBOR PHARMACEUTICALS, LLC
A61K31/18A61K9/0053A61K9/08A61K47/02A61K47/12A61K47/22A61K47/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,850,222
App. No.
17/036,790
Granted
Dec 26, 2023
Kind
B2
Abstract

The present invention provides oral solutions containing sotalol hydrochloride which advantageously avoid swallowing while providing with improved stability. The present invention also relates to methods of using the oral solutions for treatment of diseases and disorders, such as delay in reoccurrence of atrial fibrillation/atrial flutter and/or ventricular arrhythmias.

Claims (25)

1. A method of treating ventricular arrhythmia in a patient in need thereof comprising administering an oral solution comprising sotalol hydrochloride,

wherein the oral solution is administered in a dose of about 80 mg sotalol hydrochloride once or twice daily; and

wherein (i) the oral solution is administered in a dose of about 80 mg sotalol hydrochloride twice a day in a patient with a creatinine clearance greater than 60 mL/min or (ii) the oral solution is administered in a dose of about 80 mg sotalol hydrochloride once a day in a patient with a creatinine clearance between 40 and 60 mL/min.

2. The method of claim 1 , wherein the ventricular arrhythmia is ventricular tachycardia.

3. The method of claim 1 , wherein the ventricular arrhythmia is ventricular fibrillation.

4. The method of claim 1 , wherein the dose is increased up to 320 mg sotalol hydrochloride once or twice a day.

5. The method of claim 1 , wherein the dose is increased in increments of 80 mg sotalol hydrochloride per day for three days.

6. The method of claim 1 , further comprising monitoring the QT interval corrected for heart rate (QTc) of the patient during dose escalation.

7. A method of delaying recurrence of atrial fibrillation/atria flutter in a patient in need thereof comprising administering an oral solution comprising sotalol hydrochloride,

wherein the oral solution is administered in a dose of about 80 mg sotalol hydrochloride once or twice daily, and

wherein (i) the oral solution is administered in a dose of about 80 mg sotalol hydrochloride twice a day in a patient with a creatinine clearance greater than 60 mL/min or (ii) the oral solution is administered in a dose of about 80 mg sotalol hydrochloride once a day in a patient with a creatinine clearance between 40 and 60 mL/min.

8. The method of claim 7 , wherein the dose is increased up to 320 mg sotalol hydrochloride once or twice a day.

9. The method of claim 7 , wherein the dose is increased in increments of 80 mg sotalol hydrochloride per day for three days.

10. The method of claim 7 , further comprising monitoring the QT interval corrected for heart rate (QTc) of the patient during dose escalation.

11. A method of treating ventricular arrhythmia in a patient in need thereof comprising administering an oral solution comprising sotalol hydrochloride,

wherein the oral solution is administered in a dose of about 80 mg sotalol hydrochloride once or twice daily, and

wherein the method further comprises monitoring the QT interval corrected for heart rate (QTc) of the patient during dose escalation.

12. The method of claim 11 , wherein the ventricular arrhythmia is ventricular tachycardia.

13. The method of claim 11 , wherein the ventricular arrhythmia is ventricular fibrillation.

14. The method of claim 11 , wherein the dose is increased up to 320 mg sotalol hydrochloride once or twice a day.

15. The method of claim 11 , wherein the dose is increased in increments of 80 mg sotalol hydrochloride.

16. A method of delaying recurrence of atrial fibrillation/atria flutter in a patient in need thereof comprising administering an oral solution comprising sotalol hydrochloride,

wherein the oral solution is administered in a dose of about 80 mg sotalol hydrochloride once or twice daily, and

wherein the method further comprises monitoring the QT interval corrected for heart rate (QTc) of the patient during dose escalation.

17. The method of claim 16 , wherein the dose is increased in increments of 80 mg sotalol hydrochloride.

Assignments (7)
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Mar 17, 2025
From: ARBOR PHARMACEUTICALS, LLC; AZURITY PHARMACEUTICALS, INC.; AZURITY PHARMACEUTICALS IRELAND LIMITED; SILVERGATE PHARMACEUTICALS, INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070531/0487 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2024
From: ARBOR PHARMACEUTICALS, INC.
To: ARBOR PHARMACEUTICALS, LLC
Reel/Frame 066391/0695 →
SECURITY INTEREST Recorded Sep 20, 2021
From: ARBOR PHARMACEUTICALS, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057544/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2021
From: ARBOR PHARMACEUTICALS, INC.
To: ARBOR PHARMACEUTICALS, LLC
Reel/Frame 057440/0387 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2020
From: THOMAS, H. GREG; KIEL, JEFFREY S.
To: ARBOR PHARMACEUTICALS, INC.
Reel/Frame 053934/0444 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2020
From: ARBOR PHARMACEUTICALS, INC.
To: ARBOR PHARMACEUTICALS, LLC
Reel/Frame 053934/0519 →